"Revolutionary One-Shot Vaccine Strategy Offers Universal Protection Against Virus Strains"
Scientists at UC Riverside have developed a new RNA-based vaccine strategy that targets a part of the viral genome common to all strains of a virus, potentially eliminating the need for annual vaccine updates. The vaccine has been shown to be effective against any strain of a virus and can be safely used by babies or the immunocompromised. It relies on small, silencing RNA molecules to weaken the virus and boost the body's immune response, making it suitable for a broad spectrum of people. The researchers believe this strategy could lead to a one-and-done vaccine for various viruses, including influenza and respiratory infections, and may be applicable to viruses like dengue, SARS, and COVID.